Meghan Rose McGillin (Cornell University) has written a post on key insights from ASM Microbe 2023, with a focus on how much phage work was presented. She highlights new developments in phage therapy, including breakthroughs targeting B. cepacia and using cocktails to treat catheter-associated UTIs, as well as insights from APT’s CEO on phage therapy commercialization.